截至 2025 年 7 月 31 日花旗集团将其在凯莱英医药集团(Asymchem Laboratories Tianj

智通财经
Aug 06
截至 2025 年 7 月 31 日花旗集团将其在凯莱英医药集团(Asymchem Laboratories Tianjin Co Ltd)的非净空头头寸减少 20.53%至 589,675 股占该公司股票的 2.14%。根据监管披露信息至少有四名投资者披露了对总部位于中国天津的凯莱英的空头头寸。已披露的空头头寸共计 109 万股占该公司流通股的 3.95%。花旗集团持有最大的空头头寸。请注意该头寸未计入潜在的对冲或套利操作。本分析仅包含 0.5% 及以上的空头头寸。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10